PhRMA President and CEO Steve Ubl and Joe Grogan, a former Trump assistant and director of the White House’s Domestic Policy Council, took aim at the 340B program in a pair of recent op-eds.

Drug Industry Takes Aim at 340B Program’s Growth in Pair of Op-Eds

July 1, 2025 Shannon Young, Associate Editor/Senior Writer Views

The head of an influential drug industry trade group and a former Trump administration official recently called for federal 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

Drug Industry Takes Aim at 340B Program’s Growth in Pair of Op-Eds

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Shannon Young

Drug Industry Takes Aim at 340B Program’s Growth in Pair of Op-Eds

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Shannon Young

Staff Email

Site Footer Live